Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001209191-23-056548

Director sold 1,943 shares at $0.90 ($1,751)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ENGLEMAN EDGAR Director 2023-11-21 Sale −1,707 $0.90 $1,539 1,952,302 I
ENGLEMAN EDGAR Director 2023-11-21 Sale −236 $0.90 $213 269,587 I
Open-market sales · 1,943 sh · avg $0.90 · $1,751
Loading xslF345X05/doc4.xml…